HiveProspectStranded Biotech Asset IntelligenceResearch intelligence
Research workspace tools

Sulfadoxine Pyrimethamine

TERMINATED · PHASE4 · Malaria

The study was terminated because of Early Treatment Failure in child.The justification for this decision are concerns about safety of children.

Registry source

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.